Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06223178
Other study ID # 2023ZX010-DOR
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 3, 2023
Est. completion date December 30, 2025

Study information

Verified date January 2024
Source The Third Affiliated hospital of Zhejiang Chinese Medical University
Contact Xiaomei Shao, Ph.D
Phone +8618957130287
Email shaoxiaomei@zcmu.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Diminished Ovarian Reserve (DOR) is characterized as an important cause of infertility. Acupuncture has been extensively used to treat female infertility. This study was conducted to investigate the efficacy of thumb-tack needle,as a new special type of acupuncture and long-lasting treatment modality,in the treatment of DOR.


Description:

There will be a multi-center, randomized, sham-controlled trial. 106 patients will be randomly assigned into thumb-tack needle acupuncture or sham-acupuncture in 1:1 ratio. All the patents will achieve 12 sessions of verum or sham treatments in 20 weeks(12 weeks for treatment and 8 weeks for follow-up). Patients, outcome assessors and statisticians are masked from group assignment. The study is aim to evaluate the efficacy of thumb-tack needle for DOR.


Recruitment information / eligibility

Status Recruiting
Enrollment 106
Est. completion date December 30, 2025
Est. primary completion date December 30, 2025
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 39 Years
Eligibility Inclusion Criteria: - 18 years old = age < 40 years old, female; - Clinical diagnosis of Diminished Ovarian Reserve: meet both items in twice tests with an interval of at least 4 weeks(tested between 2rd to 4th day of menstrual cycle): 1. 10 IU/L < FSH < 20 IU/L, 2. Anti-Müllerian hormone(AMH) < 1.1ng/mL. - without any mind disease, willing to participate in the study and sign the informed consent. - without any other treatment. Exclusion Criteria: - Low or no response to exogenous gonadotropins, or with congenital anomalies in the development of the reproductive tract; - Pregnant or breastfeeding; - Abnormal body temperatures at the moment; - Psychopath, alcoholic, Patient with severe depression, history of substance abuse and severe primary diseases of cardiovascular, liver, kidney and hematopoietic system; - Currently enrolled in other clinical trials or refuse to cooperate with the study protocol.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
thumb-tack needle
Sterilizing skin and avoiding vessels, the thumb-tack needle are directly stock to the surface of acupoints by a band-aid, kneading and pressing for 5 minutes. The thumb-tack needle will be embedded in the skin and keep staying for 72 hours. Patients will be taught to press them 3 to 4 times per day. As tolerated by them, each pressing will lasts 1 minutes with an interval of about 4 hours.
sham thumb-tack needle
Sterilizing skin and avoiding vessels, the sham thumb-tack needle are directly stock to the surface of acupoints by a band-aid, kneading and pressing for 5 minutes. The sham device will be embedded in the skin and keep staying for 72 hours. Patients will be taught to press them 3 to 4 times per day. As tolerated by them, each pressing will lasts 1 minutes with an interval of about 4 hours.
Other:
Basic gynecological treatment
Gynecological health care guidance will be provided as patients needed.

Locations

Country Name City State
China the Third affiliated hospital of Zhejiang Chinese Medical university Hangzhou Zhejiang

Sponsors (2)

Lead Sponsor Collaborator
Xiaomei Shao Hangzhou Hospital of Traditional Chinese Medicine

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary changes of serum follicle-stimulating hormone (FSH) level The increasing of serum follicle-stimulating hormone(FSH) is one of the main symptoms of Diminished Ovarian Reserve. The normal value of FSH is 1.37-9.9 U/L in follicular phase, and higher the FSH value, the worse ovarian function. Patients in this study will be asked to take the serum FSH text between day2 to day4 of menstrual period in whole observation. Patients with amenorrhea take every 28 days as a supposed menstrual cycle instead. baseline,week 4, week 12,week 20(week 8 in follow-up)
Secondary changes of 1.Serum Anti-Müllerian Hormone (AMH) level AMH is another recommend index to measure ovarian function. Compared to FSH, Anti-Müllerian Hormone has less fluctuation and more accuracy. The normal value of serum AMH is 2-6.8ng/ml in follicular phase, and lower the value, the worse condition. baseline,week 12, week 20(week 8 in follow-up)
Secondary temperature of sensitized acupoint "Acupoint sensitization" suggests that there are specific changes of biological characteristics on the body surface or acupuncture points in a pathological state. Acupoints associated with the disease may manifest as sensitivity to pain and heat. Infrared thermography (IRT) will be used to measured the temperature of the DOR-related acupoints. baseline,week 4, week 12,week 20(week 8 in follow-up)
Secondary pain threshold of sensitized acupoint Pain threshold of DOR-related acupoints will be tested by pressure pain threshold gauge (PTG). baseline,week 4, week 12,week 20(week 8 in follow-up)
Secondary the modified Kupperman Index(KI) The modified Kupperman Index (KI) is widely used for female self-evaluation of the severity of menopausal symptoms in clinical practice. It values 13 items of menopausal symptoms on a scale of 0 to 3. The final score of KI is the sum of each score multiplied with the base score respectively, ranging from 0-63. The final KI score is less than 6 means normal, between 6 to 15 are classified as mild, 16 to 30 as moderate, and greater than 30 as severe. baseline,week 4, week 12,week 20(week 8 in follow-up)
Secondary Self-Rating Anxiety Scale (SAS) According to the frequency of symptom occurrence, the SAS contains 20 items reflecting subjective feelings of anxiety, and each item is rated on a four-point scale of 1 to 4, including 15 positive and 5 negative items. 1 means never, 2 is for sometimes, 3 is for frequently, 4 is always. Positive items are rating from 1-4, while negative items is from 4 to 1. Once the evaluation is complete, the scores for each of the 20 items are added together as score X. Score X will multiply by 1.25 and then round to the nearest whole number to obtain a standardized score Y, which is the final result of SAS. According to the Chinese normative results, the cut-off value of the SAS standardized score is 50, where 50-59 is mild anxiety, 60-69 is moderate anxiety, and 69 or more is severe anxiety. baseline,week 4, week 12,week 20(week 8 in follow-up)
Secondary Self-rating Depression Scale (SDS) The SDS also contains 20 items reflecting subjective feelings of depression, with 10 positive and 10 negative ratings. 1 means never, 2 is for sometimes, 3 is for frequently, 4 is always. Positive items are rating from 1-4, while negative items is from 4 to 1. Once the evaluation is complete, the scores for each of the 20 items are added together as score X. Score X will multiply by 1.25 and then round to the nearest whole number to obtain a standardized score Y, which is the final result of SDS.The cut-off value of SDS standardized score is 53, where 53 to 62 is considered as mild depression, 63 to 72 is moderate depression, and 72 or more is severe depression. baseline,week 4, week 12,week 20(week 8 in follow-up)
Secondary Psychological constitution of traditional Chinese medicine(TCM) The TCM psychological constitution scale is compiled by Professor Wang Qi of Beijing University of Chinese Medicine, which is widely used in clinical practice. There are 9 items and 66 small items in the TCM constitution scale, and it requires patients fill the scale truthfully by themselves according to their real situation in the last year. Nine psychological constitutions will be determined by conversion score: mild constitution, qi deficiency constitution, qi depression constitution, yin deficiency constitution, yang deficiency constitution, blood stasis constitution, special constitution, phlegm-dampness constitution and damp-heat constitution. baseline,week 4, week 12,week 20(week 8 in follow-up)
See also
  Status Clinical Trial Phase
Recruiting NCT04972877 - Effect of Electro-acupuncture on Women With Diminished Ovarian Reserve N/A
Recruiting NCT04447872 - The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol N/A
Recruiting NCT05277948 - Effect of Thumbtack Needle on Ovarian Function of Women With Diminished Ovarian Reserve (DOR) N/A
Recruiting NCT04711772 - Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve
Recruiting NCT03670407 - Follicular Activation by Fragmentation of Ovarian Tissue N/A
Recruiting NCT06072794 - A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI) Phase 1
Recruiting NCT06096766 - the Correlation Between Ovarian Function and Serum Biomarkers
Not yet recruiting NCT02099916 - Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF Phase 2/Phase 3
Not yet recruiting NCT06081257 - The Effect of "KB-120" Small Molecular Nutrient in Women With Decreased Ovarian Reserve N/A
Recruiting NCT06426355 - The Effeciency of NMN in Improving IVF/ICSI-ET Pregnancy Outcomes in Patients With DOR N/A
Recruiting NCT04275700 - Study of PRP in Women With Evidence of Diminished Ovarian Reserve N/A
Not yet recruiting NCT05577455 - Efficacy of Traditional Chinese Medicine on Ameliorating IVF-ET Outcomes of Diminished Ovarian Reserve Patients Phase 3
Not yet recruiting NCT05459493 - A Clinical Study of Chinese Herbal Compound TJAOA101 in Therapy of Diminished Ovarian Reserve Early Phase 1
Recruiting NCT05665010 - Precise Stratification of Genetic Risk of Ovarian Function Impairment
Not yet recruiting NCT05385848 - Autologous Platelet-rich Plasma (PRP) Infusion to Improve Outcomes in Women With Ovarian Insufficiency: a Pilot Study N/A
Terminated NCT01614067 - Delayed Start to Ovarian Stimulation Phase 4
Recruiting NCT06395623 - Study of Acupoints in Diminished Ovarian Reserve Based on Biological Characteristics
Recruiting NCT05847283 - DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT N/A
Recruiting NCT05485610 - Effect of NMN (Nicotinamide Mononucleotide) on Diminished Ovarian Reserve (Including Premature Ovarian Insufficiency) N/A
Completed NCT04237909 - Effects of Intraovarian Platelet Rich Plasma in Women With Poor Ovarian Response and Premature Ovarian Insufficiency N/A